Gender- and age-specific risk factors for wheeze from birth through adolescence

Sze Man Tse1,2, Brent A Coull3, Joanne E Sordillo1

  • 1Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Pediatric Pulmonology
|October 29, 2014
PubMed

Insights

This study identified gender-specific risk factors for childhood wheeze, finding maternal asthma affects both genders, while paternal asthma and infant bronchiolitis pose risks only for boys. Early identification can personalize asthma treatment.

Area of Science:

  • Pediatric Pulmonology
  • Epidemiology
  • Genetics and Asthma

Background:

  • Longitudinal studies on gender-specific wheeze risk factors are limited.
  • Understanding early life influences on wheeze is crucial for effective intervention.
  • Wheeze prevalence shows cross-sectional gender differences, necessitating a longitudinal perspective.

Purpose of the Study:

  • To identify gender- and age-specific risk factors for wheeze from birth through adolescence.
  • To explore the impact of parental history of atopy on wheeze development.
  • To inform personalized asthma management strategies.

Main Methods:

  • A prospective birth cohort of 499 children with parental history of atopy was followed.
  • Wheeze incidence was recorded every six months up to age 14.
  • Generalized estimating equations were used to analyze gender- and age-specific risk factors.

Main Results:

  • Maternal asthma was a significant risk factor for wheeze in both girls (OR=2.05) and boys (OR=1.79).
  • Paternal asthma (OR=1.83) and infant bronchiolitis (OR=2.15) were identified as risk factors exclusively for boys.
  • These risk factors demonstrated consistent effects across different ages.

Conclusions:

  • This study successfully identified gender- and age-specific risk factors for wheeze in a birth cohort.
  • Recognizing gender-specific early-life risks can enable timely interventions.
  • Findings support a more personalized approach to asthma treatment and management.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
26
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
22
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
19
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
23
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.5K